{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:02:31Z","timestamp":1761930151945,"version":"3.41.2"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"DOI":"10.3389\/fpubh.2020.00444","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T11:31:15Z","timestamp":1600774275000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality\u2014Perspectives"],"prefix":"10.3389","volume":"8","author":[{"given":"Mark Christopher","family":"Arokiaraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e01174","DOI":"10.1128\/mBio.01174-14","article-title":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses","volume":"5","author":"Menachery","year":"2014","journal-title":"mBio."},{"key":"B2","doi-asserted-by":"publisher","first-page":"9065","DOI":"10.1073\/pnas.0800502105","article-title":"Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution","volume":"105","author":"Zeng","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury","volume":"4","author":"Yang","year":"2014","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","article-title":"Influenza A virus cell entry, replication, virion assembly and movement","volume":"9","author":"Dou","year":"2018","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fmicb.2012.00117","article-title":"Cell receptors for influenza A viruses and the innate immune response","volume":"3","author":"Ramos","year":"2012","journal-title":"Front Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virusres.2014.03.010","article-title":"Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus","volume":"185","author":"Liu","year":"2014","journal-title":"Virus Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3389\/fimmu.2018.01366","article-title":"Streptococcus pneumoniae's virulence and host immunity: aging, diagnostics, and prevention","volume":"9","author":"Brooks","year":"2018","journal-title":"Front Immunol."},{"key":"B9","unstructured":"Efficacy and effectiveness of pneumococcal vaccination in elderly \u2013 an update of the literature\n            WinjeBA\n            BerildJ\n            VestrheimDF\n            DensionE\n            LeppT\n            RothA\n          Norwegian Institute of Public Health2019"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front Microbiol"},{"key":"B11","unstructured":"ArokiarajMC\n          Considering Interim Interventions to Control COVID-19 Associated Morbidity and Mortality \u2013 The Perspectives"},{"key":"B12","unstructured":"Influenza Vaccination Rates (indicator)2020"},{"key":"B13","unstructured":"LisewskiAM\n          Association Between Influenza Vaccination Rates and SARS-CoV-2 Outbreak Infection Rates in OECD Countries"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e82898","DOI":"10.5812\/semj.82898","article-title":"Seasonal influenza vaccination uptake and its socioeconomic determinants in patients and staff of hospitals in Shahroud, Northeast of Iran","volume":"20","author":"Aliyari","year":"2019","journal-title":"Shiraz E-Med J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"w14705","DOI":"10.4414\/smw.2019.14705","article-title":"Trends in influenza vaccination uptake in Switzerland: Swiss health survey 2007 and 2012","volume":"149","author":"Z\u00fcrcher","year":"2019","journal-title":"Swiss Medical Wkly."},{"key":"B16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21101\/cejph.a5010","article-title":"Influenza vaccination in Austria: persistent resistance and ignorance to influenza prevention and control","volume":"27","author":"Kunze","year":"2019","journal-title":"Central Eur J Public Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study (2016)","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2018034","DOI":"10.4178\/epih.e2018034","article-title":"The coverage rates for influenza vaccination and related factors in Korean adults aged 50 and older with chronic disease: based on (2016). Community health survey data","volume":"40","author":"Byeon","year":"2018","journal-title":"Epidemiol Health."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/epirev\/mxj003","article-title":"Immunization to protect the US armed forces: heritage, current practice, and prospects","volume":"28","author":"Grabenstein","year":"2006","journal-title":"Epidemiol Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.amepre.2006.07.018","article-title":"Racial\/Ethnic differences in influenza vaccination in the veterans affairs healthcare system","volume":"31","author":"Straits-Tr\u00f6ster","year":"2006","journal-title":"Am J Prev Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e001019","DOI":"10.1136\/bmjopen-2012-001019","article-title":"Seasonal influenza vaccine effectiveness in the community (SIVE): protocol for a cohort study exploiting a unique national linked data set","volume":"2","author":"Lone","year":"2020","journal-title":"BMJ Open"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2000256","DOI":"10.2807\/1560-7917.ES.2020.25.12.2000256","article-title":"Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the diamond princess cruise ship, February 2020","volume":"25","author":"Russell","year":"2020","journal-title":"Eurosurveillance."},{"key":"B23","unstructured":"Cruise Ships"},{"key":"B24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","article-title":"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study","volume":"396","author":"Poll\u00e1n","year":"2020","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.29.174888","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","author":"Sekine","year":"2020","journal-title":"bioRxiv."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.09.20148429","article-title":"Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection","author":"Seow","year":"2020","journal-title":"medRxiv."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.06.080960","article-title":"The transcriptomic profiling of COVID-19 compared to SARS, MERS, Ebola, and H1N1","author":"Alsamman","year":"2020","journal-title":"bioRxiv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1084\/jem.20181624","article-title":"Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies","volume":"216","author":"Kosik","year":"2019","journal-title":"J Exp Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"010433","DOI":"10.7189\/jogh.09.010433","article-title":"Epidemiology of viral acute lower respiratory infections in a community-based cohort of rural north Indian children","volume":"9","author":"Krishnan","year":"2019","journal-title":"J Glob Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/cid\/cix565","article-title":"Burden of influenza in 4 ecologically distinct regions of Peru: household active surveillance of a community cohort, 2009-2015","volume":"65","author":"Tinoco","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","article-title":"Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the global burden of disease study 2017","volume":"7","author":"Troeger","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","author":"Long","year":"2020","journal-title":"Nat Med."},{"key":"B34","unstructured":"COVID-19 Severity in Europe and the USA: Could the Seasonal Influenza Vaccination Play a Role?"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.17.20097410","article-title":"COVID-19 death rates by age and sex and the resulting mortality vulnerability of countries and regions in the world","author":"Guilmoto","year":"2020","journal-title":"medRxiv."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.jval.2019.07.001","article-title":"Cost-effectiveness analysis for influenza vaccination coverage and timing in tropical and subtropical climate settings: a modelling study","volume":"22","author":"Yue","year":"2019","journal-title":"Value Health."},{"key":"B37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/imm.13005","article-title":"Recent advances on the crosstalk between neutrophils and B or T lymphocytes","volume":"156","author":"Costa","year":"2018","journal-title":"Immunology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13059-016-0921-4","article-title":"Talking about cross-talk: the immune system and the microbiome","volume":"17","author":"Zeevi","year":"2016","journal-title":"Genome Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41467-018-07932-1","article-title":"On chaotic dynamics in transcription factors and the associated effects in differential gene regulation","volume":"10","author":"Heltberg","year":"2019","journal-title":"Nat Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2015.00277","article-title":"Maraviroc - A CCR5 antagonist for the treatment of HIV-1 infection","volume":"6","author":"Van Der Ryst","year":"2015","journal-title":"Front Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/gut.2004.055699","article-title":"The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source","volume":"54","author":"Goulding","year":"2005","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.30.927871","article-title":"Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag","author":"Pradhan","year":"2020","journal-title":"bioRxiv."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3389\/fimmu.2017.01981","article-title":"The expanding therapeutic perspective of CCR5 blockade","volume":"8","author":"Vangelista","year":"2018","journal-title":"Front Immunol."},{"year":"","key":"B44","article-title":"Genetics Home Reference"},{"key":"B45","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.1074\/jbc.RA117.001067","article-title":"Regulation of C-C chemokine receptor 5 (CCR5) stability by Lys197 and by transmembrane protein aptamers that target it for lysosomal degradation","volume":"293","author":"Petti","year":"2018","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2004.07.014","article-title":"Soluble chemokine CCR5 receptor is present in human plasma","volume":"96","author":"Tsimanis","year":"2005","journal-title":"Immunol Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.1921186117","article-title":"Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection","volume":"117","author":"Sun","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.13.082180","article-title":"A novel method of immunomodulation of endothelial cells using streptococcus pyogenes and its lysate","author":"Arokiaraj","year":"2020","journal-title":"biorxiv."},{"key":"B49","unstructured":"Current approaches to group a streptococcal vaccine development\n            DaleJB\n            BatzloffMR\n            ClearyPP\n            CourtneyHS\n            GoodMF\n            GrandiG\n          \n            FerrettiJJ\n            StevensDL\n            FischettiVA\n          Oklahoma City, OKUniversity of Oklahoma Health Sciences CenterStreptococcus Pyogenes: Basic Biology to Clinical Manifestations2016"},{"key":"B50","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/cid\/ciy1143","article-title":"The path to group A streptococcus vaccines: world health organization research and development technology roadmap and preferred product characteristics","volume":"69","author":"Vekemans","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ilar\/ilx026","article-title":"Are RNA viruses candidate agents for the next global pandemic?","volume":"58","author":"Carrasco-Hernandez","year":"2017","journal-title":"ILAR J"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2020.00444\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T11:31:22Z","timestamp":1600774282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2020.00444\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":51,"alternative-id":["10.3389\/fpubh.2020.00444"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2020.00444","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"article-number":"444"}}